McKool Smith principal Kevin Schubert, along with other colleagues, will discuss "the difficulties, pros, and cons of the proposed waiver of COVID-19 patents for drugs and vaccines under IP provisions of the TRIPS Agreement submitted to the WTO (World Trade Organization)" at the upcoming DC Bar's remote program titled "Proposed Waiver of COVID19 Patents." For more information and registration, click here.
